Evidence map›Paper›PMID 40824234›Full record

ArticlePsychiatry and clinical psychopharmacology2025

Exploring the Modulatory Effects of Vitamin B12 on Morphine-Induced Conditioned Place Preference in Rats.

Tuğçe Uskur, Fatma Ünlü Taşdemir, Mehmet Aykut Öztürk, Haktan Sönmez, Zeynep Gizem Todurga Seven, Selim Gökdemir, Burak Baştan, Gökhan Faikoğlu, Saygısever Faikoğlu Kübra, Sibel Özyazgan and 2 more

Abstract read
In one paragraph

Article in Psychiatry and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tuğçe UskurDepartment of Medical Pharmacology, Kırklareli University Faculty of Medicine, Kırklareli, Türkiye.ORCID 0000-0001-6626-4859
Fatma Ünlü TaşdemirDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-2961-2145
Mehmet Aykut ÖztürkDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-3681-6752
Haktan SönmezDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0001-7566-2170
Zeynep Gizem Todurga SevenDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-2529-0118
Selim GökdemirDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0003-4551-3013
Burak BaştanDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-6144-5148
Gökhan FaikoğluDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-8980-4499
Saygısever Faikoğlu KübraDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-4723-8580
Sibel ÖzyazganDepartment of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, İstanbul University - Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-2511-3541
Dündar Okan YıllarDepartment of Medical Pharmacology, Beykent University Faculty of Medicine, Istanbul, Türkiye.ORCID 0000-0003-3564-2284
Ahmet Gökhan AkkanDepartment of Medical Pharmacology, Bezmialem Vakıf University Faculty of Medicine, İstanbul, Türkiye.ORCID 0000-0002-6799-1721

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aims to investigate the effects of vitamin B12 on morphine-induced conditioned place preference (CPP), a model commonly used to assess the rewarding effects of drugs. Morphine is a potent analgesic widely used for moderate to severe pain, but it also poses a significant risk of addiction. Previous studies suggest that cyanocobalamin (vitamin B12) may enhance the analgesic effects of morphine and reduce tolerance, but its impact on morphine addiction remains unclear. Methods: The experiment followed phases of habituation, pre-conditioning, conditioning, and post conditioning. Adult male Wistar albino rats (250-300 g) were randomly divided into 3 groups (n=8 per group): control (saline), morphine (10 mg/kg), and a combination group of vitamin B12 (2 mg/kg) with morphine. The effects of saline, morphine, and the morphine-vitamin B12 combination on CPP were assessed. All drugs and saline were administered intraperitoneally (ip). Results: Morphine (10 mg/kg) significantly induced CPP compared to the saline group (P < .0001). Vitamin B12 (2 mg/kg) did not produce a statistically significant difference in morphine-induced CPP compared to the control group. Conclusion: Morphine induces a significant place preference, and vitamin B12 did not produce a statistically significant difference in reducing this effect. Further research with different doses of vitamin B12 is necessary to fully investigate these effects.

Identifiers

PMID40824234
PMCPMC12371738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.